On March 5, 2021 join leading experts in cancer immunotherapy as they present an overview of the recently published "Society for Immunotherapy of Cancer (SITC) Clinical Practice guideline on Immune Effector Cell-related Adverse Events" during a live webinar.
This FREE CME-, CNE-, CPE-certified webinar is a chance for healthcare providers who treat cancer patients, including oncologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants to learn about the recommendations from the published guideline on immune effector cell-related adverse events.
This webinar will feature discussion of:
- SITC's cancer immunotherapy guidelines on immune effector cell-related adverse events
- Properly monitoring patients receiving immune effector cell therapies for treatment-related adverse events and identifying those at high risk
- Identifying common and uncommon toxicities that may occur with immune effector cell therapies
- Determining appropriate management techniques for common adverse events resulting from immune effector cell therapies
A dedicated question-and-answer session during the webinar will provide an opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.
- Moderator: Stephan Grupp, MD, PhD – Children’s Hospital of Philadelphia and University of Pennsylvania (Expert Panel Chair)
- Matthew J. Frigault, MD, MSc – Massachusetts General Hospital (Expert Panel Member)
- Frederick L. Locke, MD – H. Lee Moffitt Cancer Center & Research Institute (Expert Panel Member)
- Bianca D. Santomasso, MD, PhD – Memorial Sloan Kettering Cancer Center (Expert Panel Member)
- 3–3:05 p.m. ET Overview: welcome and introductions
- 3:05–3:40 p.m. ET Presentation and discussion of guideline content from faculty experts
- 3:40–3:55 p.m. ET Question and answer session
- 3:55–4 p.m. ET Closing remarks
Click here to register for this webinar.
Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.
Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer
This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.